Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisha Hughes

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
BMC Genetics|July 2, 2016
Classification of genetic variants in genes associated with Lynch syndrome using a clinical history weighting algorithmBrian Morris, Elisha Hughes, Eric Rosenthal, et al.
JCO Precision Oncology|January 12, 2023
Cancer Risk Associated With <i>PTEN</i> Pathogenic Variants Identified Using Multigene Hereditary Cancer Panel TestingShelly Cummings, Andrew Alfonso, Elisha Hughes, et al.
JCO Precision Oncology|February 17, 2022
Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in WomenAllison W Kurian, Elisha Hughes, Elizabeth A Handorf, et al.
JCO Precision Oncology|September 14, 2020
Impact of a Cancer Gene Variant Reclassification Program Over a 20-Year PeriodLisa Esterling, Ranjula Wijayatunge, Krystal Brown, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
Prediction of distant recurrence in resected stage I and II lung adenocarcinomaBeatrice Aramini, Christian Casali, Alessandro Stefani, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 29, 2021
Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated (<i>ATM</i>) Gene are Associated with High and Moderate Risks for Multiple CancersMichael J Hall, Ryan Bernhisel, Elisha Hughes, et al.
Cancer|January 14, 2014
Comprehensive sequencing of PALB2 in patients with breast cancer suggests PALB2 mutations explain a subset of hereditary breast cancerPriscilla H Fernandes, Jennifer Saam, Jenny Peterson, et al.
Breast Cancer Research and Treatment|April 21, 2023
The association between age at breast cancer diagnosis and prevalence of pathogenic variantsMary B Daly, Eric Rosenthal, Shelly Cummings, et al.
Biomarkers in Medicine|July 10, 2015
Analytical validation of a proliferation-based molecular signature used as a prognostic marker in early stage lung adenocarcinomaM Bryan Warf, Placede G Fosso, Elisha Hughes, et al.
JAMA Network Open|June 17, 2026
Polygenic Risk Scores for Breast Cancer Among African American Women With High RiskYijia Sun, Timothy Simmons, James L Li, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
BMC Genetics|July 2, 2016
Classification of genetic variants in genes associated with Lynch syndrome using a clinical history weighting algorithmBrian Morris, Elisha Hughes, Eric Rosenthal, et al.
JCO Precision Oncology|January 12, 2023
Cancer Risk Associated With <i>PTEN</i> Pathogenic Variants Identified Using Multigene Hereditary Cancer Panel TestingShelly Cummings, Andrew Alfonso, Elisha Hughes, et al.
JCO Precision Oncology|February 17, 2022
Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in WomenAllison W Kurian, Elisha Hughes, Elizabeth A Handorf, et al.
JCO Precision Oncology|September 14, 2020
Impact of a Cancer Gene Variant Reclassification Program Over a 20-Year PeriodLisa Esterling, Ranjula Wijayatunge, Krystal Brown, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
Prediction of distant recurrence in resected stage I and II lung adenocarcinomaBeatrice Aramini, Christian Casali, Alessandro Stefani, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 29, 2021
Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated (<i>ATM</i>) Gene are Associated with High and Moderate Risks for Multiple CancersMichael J Hall, Ryan Bernhisel, Elisha Hughes, et al.
Cancer|January 14, 2014
Comprehensive sequencing of PALB2 in patients with breast cancer suggests PALB2 mutations explain a subset of hereditary breast cancerPriscilla H Fernandes, Jennifer Saam, Jenny Peterson, et al.
Breast Cancer Research and Treatment|April 21, 2023
The association between age at breast cancer diagnosis and prevalence of pathogenic variantsMary B Daly, Eric Rosenthal, Shelly Cummings, et al.
Biomarkers in Medicine|July 10, 2015
Analytical validation of a proliferation-based molecular signature used as a prognostic marker in early stage lung adenocarcinomaM Bryan Warf, Placede G Fosso, Elisha Hughes, et al.
JAMA Network Open|June 17, 2026
Polygenic Risk Scores for Breast Cancer Among African American Women With High RiskYijia Sun, Timothy Simmons, James L Li, et al.
Pageof 3